市场研究将来时e(MRFR)has published a cooked research report onthe “Global Dry Age-Related Macular Degeneration (AMD)Market”其中包含2018年至2027年的信息。
Thedry AMD市场is expected to register a CAGR of 8.62% during the forecast period of 2021 to 2027.
MRFR认识到以下公司key players in the global dry AMD market—Santen Pharmaceuticals Inc. (Japan), Allergan plc (Ireland), Bausch Health (Canada), Alimera Science Inc. (US), Phio Pharmaceuticals Corp (US), Ocumension Therapeutics Co. Ltd (China), Belite Bio Inc. (US), Kubota Vision Inc. (US), Iveric Bio (US), Eyestem Research Pvt Ltd (India), Yuyang DNU Co., Ltd (South Korea), and Stealth Biotherapeutics Inc. (US).
Market Highlights
预计全球干燥AMD市场预计将注册一个复合物8.62%during the forecast period and hit USD 6,113.33 millionby 2027.
Age-related Macular Degeneration (AMD) is classified as either dry macular degeneration or wet macular degeneration. Neovascular macular degeneration may proceed to wet (neovascular) AMD, marked by blood vessels growing under the retina and leaking. Dry-type occurs more frequently, although it tends to go more slowly over the years. In general, moist-type tends to produce a change in vision that happens rapidly, culminating in severe vision loss.
The growth of the dry AMD market worldwide is attributed to the growing geriatric population and increasing prevalence of age-related macular degeneration, and the introduction of novel treatment methods for dry AMD coupled with an increasing number of clinical trials focused on dry AMD. Other factors like increasing healthcare expenditure are likely to help the market grow. However, the high number of failed clinical trials for dry AMD drugs might hamper the market growth to some extent.
段分析
The global dry AMD market has been divided based on stages, age group, route of administration, diagnosis& treatment, and end user.
基于阶段的市场已被隔离为早期相关的黄斑变性，中等相关黄斑变性，晚期相关性黄斑变性。
Based on age group,the dry AMDmarket has been divided into以上75岁，60岁以上，40年以上。
Based on diagnosis & treatment, the dry AMD market has been divided intotreatment and diagnosis.Treatment type is further bifurcated into nutrition therapy and telescopic lens implant. Nutrition therapy is again divided into antioxidants and others. Antioxidants arealso segregated as vitamins, zinc, copper, omega-3 fatty acids, and others.
诊断分叉进入荧光素血管造影，初步测试，光学相干性断层扫描和其他。
Based on route of administration, the market is bifurcated into oral, intravitreal, and others.
在最终用户的基础上，市场分叉进入医院和诊所，诊断中心，学术研究机构和其他人
Access full report @//www.bjtldsoft.com/reports/dry-age-related-macular-degeneration-amd-market-10657
Regional Analysis
全球干AMD市场,基于地区en divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominated the global dry age-related macular degeneration market owing to the rising number of patients suffering from the condition. The increasing number of diabetic patients adds to the number of patients suffering from ophthalmologic conditions. The number of patients with retinal diseases such as dry AMD, retinal vein occlusion, and diabetic eye disease is steadily increasing in the US, according to a retrospective study presented during The Association for Research in Vision and Ophthalmology 2020.Europe holds the second largest market share due to the increasing older population and rising patient population. Additionally, improving government initiatives, increasing healthcare frames, and the rising demand for technologically innovative treatmentsaredriving the growth of the dry age-related macular degeneration market in Europe.The Asia-Pacific is the fastest-growing market for age-related macular degeneration as it is developing at a very rapid pace and has shown the emergence of many players. Moreover, the rising prevalence of eye disorders, increasing healthcare spending, and multinational companies moving towards the developing nations and setting operational set-ups are likely to drive the growth of the market. The Rest of the World is expected to witness a restricted growth due to limited access and healthcare affordability among the population. This region is segmented into Middle East, Africa, and Latin America. In the Middle East, the growth of the market is driven by increasing healthcare infrastructure and healthcare expenditure.
研究的主要发现